Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stegeman

Showing results (41-50 of 442) with videos related to

Pageof 45
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1997
Co-trimoxazole and Wegener's granulomatosis: more than a coincidence?C A Stegeman, J W Tervaert, C G Kallenberg
APMIS. Supplementum|January 1, 1990
Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studiesC G Kallenberg, J W Tervaert, C A Stegeman
The New England Journal of Medicine|November 25, 2003
Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesJan-Stephan F Sanders, Marjan C Slot, Coen A Stegeman
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
RAS blockade in experimental renal transplantation. Benefits and limitationsAnnemieke Smit-van Oosten, Coen A Stegeman, Harry van Goor
Revue Scientifique Et Technique (International Office of Epizootics)|October 4, 2011
Epidemiological models to assist the management of highly pathogenic avian influenzaJ A Stegeman, A Bouma, M C M de Jong
Clinical Nephrology|September 17, 2008
Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401P M Stassen, J W Cohen Tervaert, C A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2007
Use of mycophenolic acid in non-transplant renal diseasesPatricia M Stassen, Cees G M Kallenberg, Coen A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1995
Treatment of idiopathic membranous nephropathy: the dilemma of who, when, and howC A Stegeman, D de Zeeuw, P E de Jong
Clinical Immunology (Orlando, Fla.)|May 25, 2002
-463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitisWanda F Reynolds, Coen A Stegeman, Jan W Cohen Tervaert
Annals of the Rheumatic Diseases|December 21, 2006
Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamidePatricia M Stassen, Jan Willem Cohen Tervaert, Coen A Stegeman
Pageof 45

Showing results (41-50 of 442) with videos related to

Sort By:
Pageof 45
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 1997
Co-trimoxazole and Wegener's granulomatosis: more than a coincidence?C A Stegeman, J W Tervaert, C G Kallenberg
APMIS. Supplementum|January 1, 1990
Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studiesC G Kallenberg, J W Tervaert, C A Stegeman
The New England Journal of Medicine|November 25, 2003
Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesJan-Stephan F Sanders, Marjan C Slot, Coen A Stegeman
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
RAS blockade in experimental renal transplantation. Benefits and limitationsAnnemieke Smit-van Oosten, Coen A Stegeman, Harry van Goor
Revue Scientifique Et Technique (International Office of Epizootics)|October 4, 2011
Epidemiological models to assist the management of highly pathogenic avian influenzaJ A Stegeman, A Bouma, M C M de Jong
Clinical Nephrology|September 17, 2008
Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401P M Stassen, J W Cohen Tervaert, C A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2007
Use of mycophenolic acid in non-transplant renal diseasesPatricia M Stassen, Cees G M Kallenberg, Coen A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1995
Treatment of idiopathic membranous nephropathy: the dilemma of who, when, and howC A Stegeman, D de Zeeuw, P E de Jong
Clinical Immunology (Orlando, Fla.)|May 25, 2002
-463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitisWanda F Reynolds, Coen A Stegeman, Jan W Cohen Tervaert
Annals of the Rheumatic Diseases|December 21, 2006
Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamidePatricia M Stassen, Jan Willem Cohen Tervaert, Coen A Stegeman
Pageof 45